---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-29T00:22:52.170288'
end_time: '2025-12-29T00:30:05.487457'
duration_seconds: 433.32
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: NFU1
  gene_symbol: NFU1
  uniprot_accession: Q9UMS0
  protein_description: 'RecName: Full=NFU1 iron-sulfur cluster scaffold homolog, mitochondrial;
    AltName: Full=HIRA-interacting protein 5 {ECO:0000303|PubMed:11342215}; Flags:
    Precursor;'
  gene_info: Name=NFU1; Synonyms=HIRIP5 {ECO:0000303|PubMed:11342215}; ORFNames=CGI-33
    {ECO:0000303|PubMed:10810093};
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the NifU family. .
  protein_domains: FSCA_dom_sf. (IPR034904); Nfu/NifU_N. (IPR014824); Nfu/NifU_N_sf.
    (IPR036498); NIF_FeS_clus_asmbl_NifU_C. (IPR001075); Nfu_N (PF08712)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 31
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9UMS0
- **Protein Description:** RecName: Full=NFU1 iron-sulfur cluster scaffold homolog, mitochondrial; AltName: Full=HIRA-interacting protein 5 {ECO:0000303|PubMed:11342215}; Flags: Precursor;
- **Gene Information:** Name=NFU1; Synonyms=HIRIP5 {ECO:0000303|PubMed:11342215}; ORFNames=CGI-33 {ECO:0000303|PubMed:10810093};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the NifU family. .
- **Key Domains:** FSCA_dom_sf. (IPR034904); Nfu/NifU_N. (IPR014824); Nfu/NifU_N_sf. (IPR036498); NIF_FeS_clus_asmbl_NifU_C. (IPR001075); Nfu_N (PF08712)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "NFU1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'NFU1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **NFU1** (gene ID: NFU1, UniProt: Q9UMS0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9UMS0
- **Protein Description:** RecName: Full=NFU1 iron-sulfur cluster scaffold homolog, mitochondrial; AltName: Full=HIRA-interacting protein 5 {ECO:0000303|PubMed:11342215}; Flags: Precursor;
- **Gene Information:** Name=NFU1; Synonyms=HIRIP5 {ECO:0000303|PubMed:11342215}; ORFNames=CGI-33 {ECO:0000303|PubMed:10810093};
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the NifU family. .
- **Key Domains:** FSCA_dom_sf. (IPR034904); Nfu/NifU_N. (IPR014824); Nfu/NifU_N_sf. (IPR036498); NIF_FeS_clus_asmbl_NifU_C. (IPR001075); Nfu_N (PF08712)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "NFU1" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'NFU1' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **NFU1** (gene ID: NFU1, UniProt: Q9UMS0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan and verification
We verified the target as human NFU1 (UniProt Q9UMS0), a mitochondrial member of the NifU/NFU protein family that functions as a late-acting [4Fe–4S] cluster carrier in mitochondrial iron–sulfur (Fe–S) biogenesis. Literature confirms mitochondrial localization, NifU/Nfu domain architecture, and roles in late Fe–S delivery, with direct implications for MMDS1 and related phenotypes (Aug 2020 Human Molecular Genetics; Jan 2022 IUBMB Life) (jain2020assemblyofthe pages 3-4, maio2022mammalianironsulfur pages 7-9).

Comprehensive research report

1) Key concepts, definitions, and current understanding
- Identity and localization. NFU1 encodes a mitochondrial matrix protein of the NifU/NFU family with a degenerate N-terminal module and a conserved C‑terminal Nfu domain that ligates Fe–S clusters. Purified human NFU1 forms a dimer that binds a bridging [4Fe–4S] cluster, consistent with its role as a late Fe–S carrier (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597) (jain2020assemblyofthe pages 3-4, maio2022mammalianironsulfur pages 7-9).
- Molecular function in Fe–S biogenesis. NFU1 receives two [2Fe–2S] units from upstream donors and (with reducing equivalents) assembles a [4Fe–4S] center that it delivers to specific mitochondrial client proteins. Mechanistic mapping identifies a conserved hydrophobic patch at the end of the NFU1 C‑terminal α-helix essential for interactions with donors (ISCU2/ISCA1) and for cluster acquisition (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 2-2, jain2020assemblyofthe pages 16-17, jain2020assemblyofthe pages 19-20).
- Pathway positioning. Core mitochondrial Fe–S assembly begins on ISCU (primary scaffold), with HSC20–HSPA9 chaperone-cochaperone mediating release. Secondary carriers/converters (GLRX5, ISCA1/2, IBA57, BOLA3) form nodes that assemble and route [4Fe–4S] clusters to clients; NFU1 functions as a late carrier in this network (IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597; Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (maio2022mammalianironsulfur pages 7-9, jain2020assemblyofthe pages 3-4).

2) Recent developments and latest research (prioritize 2023–2024)
- Mitoribosome Fe–S clusters and METTL17. A 2023 study showed that human mitoribosomes contain three structural [2Fe–2S] clusters supplied by a GLRX5–BOLA3 node, and proposed that the mtSSU assembly factor METTL17 (with a [4Fe–4S] cluster) receives its cluster via an ISCA1–NFU1 node. Fibroblasts from NFU1 or BOLA3 patients exhibit attenuated mitochondrial protein synthesis, linking NFU1 dysfunction to translation defects in addition to canonical client maturation (Nucleic Acids Research, Oct 2023, https://doi.org/10.1093/nar/gkad842) (zhong2023bola3andnfu1 pages 1-2).
- System-level pathway mapping. Earlier mechanistic work consolidated in 2020–2022 reviews supports multiple, partially overlapping routes for [4Fe–4S] assembly/delivery to NFU1, with ISCU2→ISCA1→NFU1 as a predominant in vivo route and GLRX5–BOLA3 as an alternative or parallel node depending on client specificity (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597) (jain2020assemblyofthe pages 3-4, maio2022mammalianironsulfur pages 7-9).

3) Current applications and real-world implementations
- Clinical genetics and diagnosis. Biallelic NFU1 variants cause Multiple Mitochondrial Dysfunction Syndrome type 1 (MMDS1) characterized by early-onset leukoencephalopathy, lactic acidosis, nonketotic hyperglycinemia, and frequent pulmonary hypertension. Diagnostic work-ups leverage elevated lactate, pyruvate, and glycine, plus targeted/exome sequencing of Fe–S pathway genes (Biomedicines, Aug 2021, https://doi.org/10.3390/biomedicines9080989) (lebigot2021areviewof pages 20-21).
- Functional assays in patient cells. Complementation with wild-type NFU1 restores lipoylation and client stability; pathogenic variants fail to rescue lipoylation (PDH, OGDH) and SDHB levels, supporting variant interpretation in clinical diagnostics (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 15-16).

4) Expert opinions and analyses from authoritative sources
- Fe–S pathway positioning and disease mapping. Authoritative reviews emphasize NFU1 as a late Fe–S carrier operating with ISCA1/2, IBA57, BOLA3, and GLRX5; mutations in these factors define MMDS subtypes. Commentaries highlight the association of NFU1 dysfunction with pulmonary arterial hypertension, expanding the recognized clinical spectrum (IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597) (maio2022mammalianironsulfur pages 7-9).
- Mechanistic consolidation. Genetic, biochemical, and interaction studies support a model where NFU1 dimerizes to ligate a bridging [4Fe–4S] cluster formed by coordinated donations from ISCU2 and ISCA1, aided by FDX2; NFU1 primarily serves LIAS and, to a degree, SDHB/complex II and selected [4Fe–4S] clients (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; eLife, Aug 2016, https://doi.org/10.7554/eLife.15991) (jain2020assemblyofthe pages 14-15, melber2016roleofnfu1 pages 1-2).

5) Relevant statistics and data from recent studies
- Variant-function data. Three NFU1 missense variants (N226D, M227I, Y231C) reduce or alter interactions with ISCA1/ISCU2 and fail to complement NFU1 loss in patient fibroblasts, evidenced by lack of restoration of PDH/OGDH lipoylation and SDHB protein levels (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 15-16).
- Transcriptional compensation. NFU1-deficient patient cells upregulate ISCU and ISCA1 mRNAs under both normoxia and 2.5% O2, indicating compensatory responses within the Fe–S network (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 14-15).
- Mitochondrial translation attenuation. Patient fibroblasts with NFU1 or BOLA3 mutations show decreased mitochondrial protein synthesis, consistent with impaired mitoribosome cluster assembly (Nucleic Acids Research, Oct 2023, https://doi.org/10.1093/nar/gkad842) (zhong2023bola3andnfu1 pages 1-2).

Mechanistic pathway and client specificity
- Upstream donors and assembly on NFU1. ISCU2 (primary scaffold) and ISCA1 (secondary carrier) directly donate [2Fe–2S] clusters to NFU1; FDX2 provides electrons for reductive coupling into a [4Fe–4S] on the NFU1 dimer. Mutations at NFU1’s conserved FY/hydrophobic region abolish acquisition and delivery to clients (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 16-17, jain2020assemblyofthe pages 19-20, jain2020assemblyofthe pages 2-2).
- Alternative nodes and client routing. The GLRX5–BOLA3 node can supply [4Fe–4S] to certain clients or to NFU1 in vitro; ISCA1/2 with IBA57 assemble [4Fe–4S] for a subset of targets; HSC20–HSPA9 mediate ISCU2 release and delivery to LYR-motif clients (e.g., SDHB). Distinct phenotypes of GLRX5 versus NFU1 deficiency suggest partial pathway overlap but different physiological priorities (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; eLife, Aug 2016, https://doi.org/10.7554/eLife.15991) (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 17-18, melber2016roleofnfu1 pages 1-2).
- Primary clients and consequences. LIAS is a principal NFU1 client; NFU1 loss impairs lipoylation of PDH, OGDH, and the glycine cleavage system, explaining lactic acidosis and hyperglycinemia in MMDS1. Effects on SDHB/complex II vary with context; ISCA1 loss causes pronounced SDHB decrease whereas NFU1 patient cells show milder SDHB reduction, indicating client-specific routing (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; eLife, Aug 2016, https://doi.org/10.7554/eLife.15991) (jain2020assemblyofthe pages 14-15, melber2016roleofnfu1 pages 1-2).

Disease associations and phenotypes
- MMDS1 and clinical spectrum. Biallelic NFU1 variants cause MMDS1 with early-onset leukoencephalopathy, lactic acidosis, nonketotic hyperglycinemia, and frequent pulmonary hypertension; phenotypes extend to autosomal recessive spastic paraplegia in some cases. Foundational genetic studies first linked NFU1 and BOLA3 to combined respiratory chain deficiency and 2-oxoacid dehydrogenase defects with impaired lipoylation (Am J Hum Genet, Oct–Nov 2011, https://doi.org/10.1016/j.ajhg.2011.08.011; https://doi.org/10.1016/j.ajhg.2011.10.005). Later synthesis confirms these associations and diagnostic features (Biomedicines, Aug 2021, https://doi.org/10.3390/biomedicines9080989; IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597) (maio2022mammalianironsulfur pages 7-9, lebigot2021areviewof pages 20-21, melber2016roleofnfu1 pages 1-2).
- Translational defect linkage (2023). NFU1 dysfunction is newly linked to impaired mitoribosome function via METTL17 and mitoribosomal Fe–S clusters, providing an additional pathophysiological axis for MMDS1 (Nucleic Acids Research, Oct 2023, https://doi.org/10.1093/nar/gkad842) (zhong2023bola3andnfu1 pages 1-2).

Expert synthesis and open questions
- Converging evidence positions NFU1 as a selective, late [4Fe–4S] carrier with strongest, direct support for servicing LIAS, thereby controlling mitochondrial protein lipoylation. Distinct routing via ISCA1 and GLRX5–BOLA3 likely underlies client selectivity (e.g., SDHB) and phenotypic variability. Open questions include the full hierarchy between ISCA1/2–IBA57 versus GLRX5–BOLA3 routes in different tissues and stress conditions, and how redox-sensitive Fe–S elements in the mitoribosome and METTL17 integrate into metabolic signaling (Hum Mol Genet, Aug 2020; Nucleic Acids Research, Oct 2023; IUBMB Life, Jan 2022) (jain2020assemblyofthe pages 3-4, zhong2023bola3andnfu1 pages 1-2, maio2022mammalianironsulfur pages 7-9).

Embedded summary table
| Topic | Key points | Representative sources with year and DOI/URL |
|---|---|---|
| Identity / Localization / Family | NFU1 is a mitochondrial (matrix) NifU/NFU-family protein with a conserved C‑terminal Nfu domain and a degenerate N‑terminal module; mammalian NFU1 is encoded by NFU1 (UniProt Q9UMS0). | Jain et al., 2020, DOI: 10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 3-4); Maio & Rouault, 2022, DOI: 10.1002/iub.2597 (maio2022mammalianironsulfur pages 7-9) |
| Molecular function | Acts as a late‑acting [4Fe‑4S] cluster carrier: NFU1 dimerizes and ligates a bridging [4Fe‑4S] cluster that is transferred to specific mitochondrial client proteins. | Jain et al., 2020, DOI: 10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 3-4), Melber et al., 2016, DOI: 10.7554/eLife.15991 (melber2016roleofnfu1 pages 1-2) |
| Upstream donors / assembly pathway | NFU1 acquires two [2Fe‑2S] units donated by ISCU2 and ISCA1, which are reductively coupled (FDX2 provides electrons) to form the [4Fe‑4S] on NFU1; an alternative GLRX5–BOLA3 route can supply [4Fe‑4S] in vitro. | Jain et al., 2020, DOI: 10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 14-15), Melber et al., 2016 (melber2016roleofnfu1 pages 1-2) |
| Primary clients / biochemical role | Primary client is lipoyl synthase (LIAS) — NFU1 supplies the auxiliary Fe‑S cluster required for LIAS activity and thus for lipoylation of PDH, OGDH/KGDH and the glycine cleavage system; NFU1 perturbation also affects SDHB/complex II levels variably. | Jain et al., 2020, DOI: 10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 14-15), Melber et al., 2016 (melber2016roleofnfu1 pages 1-2) |
| Interaction network | Functions downstream of ISCU and the HSC20–HSPA9 cochaperone system and cooperates with ISCA1/ISCA2, IBA57, BOLA3 and GLRX5 in late mitochondrial Fe‑S maturation and delivery. | Maio & Rouault, 2022, DOI: 10.1002/iub.2597 (maio2022mammalianironsulfur pages 7-9); Jain et al., 2020 (jain2020assemblyofthe pages 3-4) |
| 2023–2024 update | NFU1 (ISCA1–NFU1 node) implicated in assembly/delivery of Fe‑S clusters required for METTL17 (a mitoribosome biogenesis factor with a [4Fe‑4S] cluster); GLRX5–BOLA3 supplies mitoribosome [2Fe‑2S] clusters; NFU1/BOLA3 deficiency attenuates mitochondrial translation. | Zhong et al., 2023, NAR, DOI: 10.1093/nar/gkad842 (zhong2023bola3andnfu1 pages 1-2) |
| Disease associations & phenotypes | Biallelic NFU1 mutations cause MMDS1 (Multiple Mitochondrial Dysfunction Syndrome type 1) with early‑onset leukoencephalopathy, lactic acidosis, non‑ketotic hyperglycinemia and frequent pulmonary hypertension; linked phenotypes include autosomal recessive spastic paraplegia (SPG93) and translation attenuation in patient fibroblasts. | Clinical/genetic studies summarized in review and experimental reports: Lebigot et al., 2021 (lebigot2021areviewof pages 20-21), Melber et al., 2016 (melber2016roleofnfu1 pages 1-2) |
| Experimental evidence types | Supported by in vitro biochemical cluster‑transfer/reconstitution, structural/interaction mapping, patient genetics (pathogenic variants and genotype–phenotype), complementation in patient fibroblasts, proteomics and enzymatic assays (lipoylation, respiratory complex abundance). | Jain et al., 2020 (jain2020assemblyofthe pages 3-4), Melber et al., 2016 (melber2016roleofnfu1 pages 1-2), Zhong et al., 2023 (zhong2023bola3andnfu1 pages 1-2) |
| Notable pathogenic variants / functional readouts | Specific NFU1 variants (e.g., N226D, M227I, Y231C) impair interactions with ISCA1/ISCU2 and fail to restore lipoylation or SDHB levels in complementation assays, linking molecular defect to biochemical loss (lipoylation, PDH/KGDH) and clinical MMDS1. | Jain et al., 2020, DOI: 10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 15-16) |


*Table: Concise table summarizing human NFU1 identity, mechanistic role in mitochondrial Fe–S [4Fe‑4S] delivery, key partners and clients, 2023 update on mitoribosome links, disease associations, and the main experimental evidence with representative citations.*

Gene symbol ambiguity and verification
- The symbol NFU1 corresponds to human NFU1 iron–sulfur cluster scaffold homolog, mitochondrial (UniProt Q9UMS0). Literature confirms mitochondrial localization, NifU/Nfu family membership, and late Fe–S carrier function in Homo sapiens; no conflicting gene targets were used in this report (Hum Mol Genet, Aug 2020, https://doi.org/10.1093/hmg/ddaa172; IUBMB Life, Jan 2022, https://doi.org/10.1002/iub.2597) (jain2020assemblyofthe pages 3-4, maio2022mammalianironsulfur pages 7-9).

Cited sources (with dates/URLs)
- Jain et al., Human Molecular Genetics, Aug 2020. https://doi.org/10.1093/hmg/ddaa172 (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 17-18, jain2020assemblyofthe pages 16-17, jain2020assemblyofthe pages 19-20, jain2020assemblyofthe pages 14-15, jain2020assemblyofthe pages 2-2)
- Zhong et al., Nucleic Acids Research, Oct 2023. https://doi.org/10.1093/nar/gkad842 (zhong2023bola3andnfu1 pages 1-2)
- Maio & Rouault, IUBMB Life, Jan 2022. https://doi.org/10.1002/iub.2597 (maio2022mammalianironsulfur pages 7-9)
- Melber et al., eLife, Aug 2016. https://doi.org/10.7554/eLife.15991 (melber2016roleofnfu1 pages 1-2)
- Lebigot et al., Biomedicines, Aug 2021. https://doi.org/10.3390/biomedicines9080989 (lebigot2021areviewof pages 20-21)
- Cameron et al., American Journal of Human Genetics, Oct 2011. https://doi.org/10.1016/j.ajhg.2011.08.011 (melber2016roleofnfu1 pages 1-2)
- Navarro-Sastre et al., American Journal of Human Genetics, Nov 2011. https://doi.org/10.1016/j.ajhg.2011.10.005 (melber2016roleofnfu1 pages 1-2)


References

1. (jain2020assemblyofthe pages 3-4): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

2. (maio2022mammalianironsulfur pages 7-9): Nunziata Maio and Tracey A. Rouault. Mammalian iron sulfur cluster biogenesis and human diseases. IUBMB Life, 74:705-714, Jan 2022. URL: https://doi.org/10.1002/iub.2597, doi:10.1002/iub.2597. This article has 26 citations and is from a peer-reviewed journal.

3. (jain2020assemblyofthe pages 2-2): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

4. (jain2020assemblyofthe pages 16-17): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

5. (jain2020assemblyofthe pages 19-20): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

6. (zhong2023bola3andnfu1 pages 1-2): Hui Zhong, Alexandre Janer, Oleh Khalimonchuk, Hana Antonicka, Eric A Shoubridge, and Antoni Barrientos. Bola3 and nfu1 link mitoribosome iron–sulfur cluster assembly to multiple mitochondrial dysfunctions syndrome. Nucleic Acids Research, 51:11797-11812, Oct 2023. URL: https://doi.org/10.1093/nar/gkad842, doi:10.1093/nar/gkad842. This article has 31 citations and is from a highest quality peer-reviewed journal.

7. (lebigot2021areviewof pages 20-21): Elise Lebigot, Manuel Schiff, and Marie-Pierre Golinelli-Cohen. A review of multiple mitochondrial dysfunction syndromes, syndromes associated with defective fe-s protein maturation. Biomedicines, 9:989, Aug 2021. URL: https://doi.org/10.3390/biomedicines9080989, doi:10.3390/biomedicines9080989. This article has 28 citations and is from a poor quality or predatory journal.

8. (jain2020assemblyofthe pages 15-16): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

9. (jain2020assemblyofthe pages 14-15): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

10. (melber2016roleofnfu1 pages 1-2): Andrew Melber, Un Na, Ajay Vashisht, Benjamin D Weiler, Roland Lill, James A Wohlschlegel, and Dennis R Winge. Role of nfu1 and bol3 in iron-sulfur cluster transfer to mitochondrial clients. eLife, Aug 2016. URL: https://doi.org/10.7554/elife.15991, doi:10.7554/elife.15991. This article has 143 citations and is from a domain leading peer-reviewed journal.

11. (jain2020assemblyofthe pages 17-18): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

## Citations

1. lebigot2021areviewof pages 20-21
2. jain2020assemblyofthe pages 15-16
3. maio2022mammalianironsulfur pages 7-9
4. jain2020assemblyofthe pages 14-15
5. jain2020assemblyofthe pages 3-4
6. jain2020assemblyofthe pages 2-2
7. jain2020assemblyofthe pages 16-17
8. jain2020assemblyofthe pages 19-20
9. jain2020assemblyofthe pages 17-18
10. 4Fe–4S
11. 2Fe–2S
12. 4Fe‑4S
13. 2Fe‑2S
14. 4fe–4s
15. 2fe–2s
16. https://doi.org/10.1093/hmg/ddaa172;
17. https://doi.org/10.1002/iub.2597
18. https://doi.org/10.1093/hmg/ddaa172
19. https://doi.org/10.1002/iub.2597;
20. https://doi.org/10.1093/nar/gkad842
21. https://doi.org/10.3390/biomedicines9080989
22. https://doi.org/10.7554/eLife.15991
23. https://doi.org/10.1016/j.ajhg.2011.08.011;
24. https://doi.org/10.1016/j.ajhg.2011.10.005
25. https://doi.org/10.3390/biomedicines9080989;
26. https://doi.org/10.1016/j.ajhg.2011.08.011
27. https://doi.org/10.1093/hmg/ddaa172,
28. https://doi.org/10.1002/iub.2597,
29. https://doi.org/10.1093/nar/gkad842,
30. https://doi.org/10.3390/biomedicines9080989,
31. https://doi.org/10.7554/elife.15991,